VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
VRTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
VRTXVertex Pharmaceuticals Incorporated
$522.25$132.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksVRTXQuarterly Cash Flow

Vertex Pharmaceuticals Incorporated (VRTX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Vertex Pharmaceuticals Incorporated (VRTX) quarterly cash flow statement — complete operating, investing & financing history

VRTX Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Cash from Operations1.43B498M1.24B1.07B818.9M584.6M1.37B-3.75B1.31B234.6M1.27B1.13B899.9M1.08B955.5M1.14B956.2M994.99M927.22M-199.77M
Operating CF Margin %47.81%15.43%40.35%36.2%29.56%20.08%49.42%-141.88%48.62%9.32%51.07%45.5%37.89%46.83%40.93%51.9%45.59%48.01%46.73%-11.14%
Operating CF Growth %74.39%-14.81%-9.37%128.59%-37.33%149.19%7.99%-430.89%45.19%-78.25%32.75%-0.47%-5.89%8.38%3.05%670.56%3.82%102.43%2.15%-119.24%
Net Income1.03B1.19B1.08B1.03B646.3M913M1.05B-3.59B1.1B968.8M1.04B915.7M699.8M818.9M930.5M810.5M762.1M770.11M851.93M66.92M
Depreciation & Amortization55.9M55.7M54M51.7M48.4M46.5M53.2M54M53.5M59M42.1M41.4M38.8M38.4M36.7M37.3M35.9M33.83M31.7M31.24M
Stock-Based Compensation166.4M157.6M194.9M167.3M166.1M167.8M184.6M154.2M191.9M208.6M130.9M119.3M122.4M111.5M135.6M113.9M130.3M118.61M103M104.62M
Deferred Taxes-65.3M30.5M-235.9M-113.8M-191.6M51.6M-123.3M-118.8M-158.3M-131M-115.5M-176.6M-113.4M148.1M-182.3M-229.4M-12.3M-41.95M68.24M-237.94M
Other Non-Cash Items-5M10.9M-4.1M67.4M418.2M-34.1M52.4M-8M-9.4M-31.9M-13.3M-10.8M13.4M52.4M-45.8M23.8M73M-20.3M-36.08M-155K
Working Capital Changes244.7M-947.8M149.6M-132.4M-268.5M-560.2M157.5M-241.4M129.3M-838.9M188.9M245.4M138.9M-90.9M80.8M383.7M-32.8M134.68M-91.56M-164.46M
Change in Receivables39.8M-99.4M-59.9M-18.4M-169.6M69M-51.8M135.1M-251.6M15.4M-6.1M-2.9M-90.5M10.2M-119.5M-84.1M-165.2M-43.53M-185.32M52.52M
Change in Inventory-97.7M-77.4M-131.1M-148.6M-167.1M-147.5M-182.5M-107.2M-80.1M-70M-97.5M-72.8M-82.6M-78.3M-26.8M-33.3M2M-26.97M-18.34M-24.71M
Change in Payables35.6M38.3M-35.3M7.6M26.2M8.4M66.1M-25.1M100K-31.8M9.2M35.6M35.7M159.9M-69.9M45.3M-14.5M53.94M2.3M-13.7M
Cash from Investing-431.9M-288.1M-117M-484.5M-55.8M-821.9M-348M-463.7M-2.14B-886.5M-117.7M-303.9M-1.83B175.6M-384.2M-61.5M-51M-134M-52.95M-79.64M
Capital Expenditures-133.4M-149.4M-101.8M-145.7M-40.7M-92.6M-67.7M-69M-68.4M-58.1M-40.6M-59.6M-42.1M-33.6M-54.2M-53.3M-63.6M-61.72M-52.52M-49.84M
CapEx % of Revenue4.47%4.63%3.31%4.91%1.47%3.18%2.44%2.61%2.55%2.31%1.63%2.39%1.77%1.46%2.32%2.43%3.03%2.98%2.65%2.78%
Acquisitions00000000000000010M077M00
Investments--------------------
Other Investing0-15.9M800K-4.3M-5.3M-30.9M-266.1M-22.7M-180M-58M-1.1M-29.9M00-295.9M-10M0-77M15M-15M
Cash from Financing-538.8M-77.2M-1.15B-349.2M-680.4M-391.3M-387.5M-358.6M-357.5M-119.8M-165M17.3M-294.7M40.2M-60.2M47.7M-95.4M-336.24M-656.66M33.55M
Debt Issued (Net)0-1.4M-1.4M-1.3M-1.3M-1.3M-5.4M-13.7M-13.2M-12M-11.3M-11M-10.6M-10.4M-49.5M-12.7M-12.9M-2.46M-11.1M-2.31M
Equity Issued (Net)-309.9M-76.9M-1.06B-342.7M-409.4M-383.6M-299.3M-265.3M-114.3M-103.1M-101.6M30.3M-118.6M51.6M36.6M64.4M33.7M-333.46M-618.48M37.94M
Dividends Paid00000000000000000000
Share Repurchases-336.9M-130.9M-1.07B-391.8M-426.1M-417.9M-307.7M-320.3M-131.2M-149.5M-117M-28.3M-132.8M0000-368.18M-632.27M0
Other Financing-228.9M1.1M-89.9M-5.2M-269.7M-6.4M-82.8M-79.6M-230M-4.7M-52.1M-2M-165.5M-1M-47.3M-4M-116.2M-316K-27.15M-2.08M
Net Change in Cash417.1M140M-34.2M296.6M113.2M-675.9M657.1M-4.58B-1.2B-744.3M963.2M857.8M-1.22B1.33B472.9M1.1B803.9M519.89M209.15M-241.84M
Free Cash Flow1.29B348.6M1.14B927.4M778.2M492M1.3B-3.83B1.06B176.5M1.23B1.07B857.8M1.04B901.3M1.09B892.6M933.2M874.8M-249.6M
FCF Margin %43.35%10.8%37.04%31.28%28.09%16.9%46.98%-144.78%39.38%7.01%49.44%43.11%36.12%45.37%38.61%49.47%42.56%45.03%44.09%-13.92%
FCF Growth %66.37%-29.15%-12.48%124.21%-26.46%178.75%6.05%-456.37%23.36%-83.11%36.23%-1.08%-3.9%11.96%3.03%535.3%5%110.26%19.35%-124.45%
FCF per Share5.051.364.423.583.001.894.99-14.844.050.684.714.133.304.013.474.203.463.633.37-0.96
FCF Conversion (FCF/Net Income)1.38x0.42x1.15x1.04x1.27x0.64x1.31x1.04x1.19x0.24x1.23x1.24x1.29x1.32x1.03x1.41x1.25x1.29x1.09x-2.98x
Interest Paid3.2M3M3.2M3.5M2.7M2.7M8.1M9.7M10M10.5M10.6M10.9M11.1M11.2M14M13.4M13.7M13.6M12.6M15.6M
Taxes Paid82.3M389.4M479.6M513.3M184.4M271.8M278.5M497M34.8M758.2M300.4M498.4M120.3M217.7M361.8M393.3M85M94.77M147.1M223.7M